Wednesday 15th July, 1:00pm - 2:00pm EDT
Presented by Walker Inman, Ph.D. and Krista Rantanen, Ph.D. Dr. Inman is the co-founder and CEO of Lucid Scientific, the developer of the RESIPHER real-time metabolic analysis platform and Dr. Krista is a Physoxia ambassador, hypoxia enthusiast and cancer researcher. Director of Scientific Applications, Baker Ruskinn.
BDandCo have announced the launch of their new portable, rapid antigen test. The test is able to detect the SARS-CoV-2 antigen within 15 minutes. The company will begin shipping the tests this week. Find out more for yourself.
Vaxart’s room temperature stable tablet vaccine has been selected for a non-human primate challenge study (NHP). The purpose of the study is to commit to the delivery of 300 million vaccine doses by 2021. Find out more.
Researchers from Chongqing University have found that the median viral shredding among asymptomatic cases of COVID-19 was 19 days versus 14 days among patients with mild symptoms. Find out more.
Axon have said that Swiss-based Bachem will help scale up its COVID-19 vaccine. The Swiss Biotech’s candidate (COVIDAX) claims it can be used to protect a broader range of people other than candidates. Find out more for yourself.
These nanosponges are able to attract and neutralize SARS-CoV-2 in cell culture, therefore causing the virus to lose its ability to hijack host cells and reproduce. Find out more.
Catalent Pharmaceutical Services, based in Anagni, Italy are prepared for around the clock manufacturing schedules, in order to complete the vial filling and packaging services for the commercialization of the University of Oxford & AstraZeneca’s vaccine candidate. Find out more.
The Daily Biologist believes that not enough emphasis is placed on interdisciplinary groups, despite it being a highly valued component of industry settings. What do you think? Find out more here.
Sign up to our monthly newsletter to stay up to date on everything that’s going on at Baker.